Chiesi Central Eastern Europe

Chiesi Central Eastern Europe is owned by Chiesi. Chiesi has a direct presence in 12 countries.

Chiesi has 12 subsidiaries including Amryt Pharma, Chiesi Central Eastern Europe and Chiesi Czech Republic.

They are in:

• Pharmaceuticals92%
• Biotechnology8%

Acquisition, funding and merger involving Chiesi.

• Chiesi has announced the acquisition of Amryt Pharma  (posted on January 13 2023).

View the org chart displaying its 10 main executives

Most searched biographies at Chiesi Central Eastern Europe

• Szilvia Murányi, Managing Director
• Georg Schmidt, Pharmaceutical Affairs Manager
• Petra Wanek, Legal & Compliance Director

Create your alert
to follow the executive moves at Chiesi Central Eastern Europe.

Chiesi has 1,865 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Chiesi Central Eastern Europe

Social media about Chiesi Central Eastern Europe

• Chiesi Central Eastern Europe on Wikipedia, Google News & Yahoo Finance
• Chiesi Central Eastern Europe on LinkedIn, Twitter & YouTube

Contact by email its executives including Szilvia Murányi

Call Chiesi Central Eastern Europe at +43 14...

View the org chart

Register to receive your alert

Report an error